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Phe Apolipoprotein CI Content of Triglyceride-Rich
ipoproteins Independently Predicts
arly Atherosclerosis in Healthy Middle-Aged Men
nders Hamsten, MD, PHD,* Angela Silveira, PHD,* Susanna Boquist, MD, PHD,† Rong Tang, MD,‡
. Gene Bond, PHD,‡ Ulf de Faire, MD, PHD,§ Johan Björkegren, MD, PHD*
tockholm, Sweden; and Winston-Salem, North Carolina
OBJECTIVES In this study, we examined the apolipoprotein (apo) CI content of triglyceride-rich
lipoproteins (TRLs) in relation to established coronary heart disease (CHD) risk factors and
early atherosclerosis.
BACKGROUND In Western society, the postprandial state constitutes a nearly constant stress on the
vasculature and the metabolism of lipoproteins. Delayed clearance of postprandial TRL
remnants has repeatedly been associated with premature CHD and may include the
enrichment of these remnants with apoCI.
METHODS We examined 72 healthy 50-year-old men with an apoE3/E3 genotype who had undergone
an oral fat load test and B-mode ultrasound examination of the intima-media thickness
(IMT) of the common carotid artery.
RESULTS In the fasting state, plasma, very-low-density lipoprotein (VLDL), and low-density lipopro-
tein cholesterol, proinsulin, and apoB100-containing intermediate density lipoprotein levels
were related to IMT (p  0.05). In the postprandial state, IMT was related to triglycerides
at 2 h (p  0.01), large VLDL concentration at 3 h (p  0.05), the apoCI plasma and TRL
concentrations at 6 h (p  0.05, p  0.05), and the apoCI content of TRLs at 6 h (p 
0.002). Multivariate analysis revealed that the apoCI content of TRLs at 6 h (p  0.0001),
plasma triglyceride concentrations at 2 h (p  0.006), and fasting plasma cholesterol
concentration (p  0.05) independently predicted IMT. In addition, the apoCI content of
postprandial TRLs correlated strongly with the cholesterol content (r  0.64, p  0.0001).
CONCLUSIONS Our results indicate that the apoCI content of postprandial TRLs is a novel independent risk
factor for early atherosclerosis in normolipidemic healthy middle-aged men with possible
implication for the enrichment of TRL remnant lipoproteins with cholesterol. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.049Cardiol 2005;45:1013–7) © 2005 by the American College of Cardiology Foundation
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rn the typical Westerner, the postprandial state influences
he metabolism of circulating lipoproteins for more than
0 h per day throughout life. However, the transience of the
ostprandial state has rendered it difficult to study, and
everal variables in the fasting state predict alterations of
ostprandial lipid metabolism (1), suggesting that postpran-
ial studies in relation to coronary heart disease (CHD)
ight not be necessary. Nevertheless, such studies typically
emonstrate postprandial accumulation of triglyceride-rich
ipoprotein (TRL) remnants in CHD patients with appar-
ntly normal fasting plasma lipoprotein profiles (2–5). Thus,
erturbations of lipid metabolism that increase the risk of
HD might be detected earlier in the postprandial state
han in the fasting state. If so, certain postprandial features
ight serve as early markers of CHD risk.
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arolinska Institutet, Stockholm, Sweden; the †Cardiology Unit, Karolinska Hospi-
al, Stockholm, Sweden; the ‡Division of Ultrasound, Department of Neurobiology
nd Anatomy, Wake Forest University, Winston-Salem, North Carolina; and the
Division of Cardiovascular Epidemiology, Institute of Environmental Medicine,
arolinska Institutet, Stockholm, Sweden. This study was supported by the Swedish
edical Research Council, the Swedish Heart-Lung Foundation, the Hans and Loo
stermans Foundation, and the Professor Nanna Svartz Foundation.I
Manuscript received October 6, 2004; revised manuscript received December 1,
004, accepted December 6, 2004.After a meal, newly synthesized TRLs are hydrolyzed by
ndothelial lipases into smaller remnant particles (6), which
re cleared from the circulation mainly by receptor-
ediated endocytosis in the liver (7). The metabolic fate of
RL particles is determined by their apolipoprotein (apo)
nd lipid composition, which governs their access to lipases
nd receptors (8,9). The structural protein apoB is an
ntegral part of every TRL particle. Of the two forms of
poB—apoB48 (synthesized in the intestine) and apoB100
synthesized in the liver)—only apoB100 has a specific
eceptor-binding site. ApoB100 and apoE are important
ediators of the clearance of circulating TRLs by receptors
10); apoE-mediated binding of TRLs to receptors is
nhibited by members of the apoC family, in particular
poCI and apoCIII (11). Apolipoprotein CII is necessary
or lipoprotein lipase-mediated hydrolysis of TRL particles
12), which is blocked by apoCIII (13) but not apoCI (14).
Our studies over the past five years have shown that
ostprandial alterations in the composition of TRLs and
RL remnant particles appear to favor their clearance from
he circulation in healthy people (15,16). However, in
atients with coronary artery disease (17) and in healthy
ubjects with early signs of atherosclerosis (18), TRL
emnants are relatively enriched in apoCI and cholesterol.
n this study, we evaluated the importance of postprandial
e
e
a
c
m
M
S
h
t
i
c
b
d
o
E
s
w
s
k
2
t
T
w
c
o
a
l

f
l
a
d
s
s
F
d
h
c
t
l
a
a
m
e
a
a
i
e
l
E
D
g
t
d
C
I
t
T
r
I
a
s
v
c
t
e
c
5
w
C
o
a
t
a
n
t
a
w
m
b
v
f
s
m
c
R
C
t
o
s
h
r
h
p
F
g
r
o
l
r
1014 Hamsten et al. JACC Vol. 45, No. 7, 2005
Apolipoprotein CI and Early Atherosclerosis April 5, 2005:1013–7nrichment of TRL particles with apoCI in relation to
stablished CHD risk factors and early atherosclerosis,
ssessed by measuring intima-media thickness (IMT) of the
ommon carotid artery by B-mode ultrasound, in healthy
iddle-aged men.
ETHODS
ubjects and study protocol. The study included 72
ealthy, 50-year-old white men with an apoE3/E3 geno-
ype who were randomly recruited from a population reg-
ster of the county of Stockholm. The exclusion criteria were
hronic disease, a history of CHD or arterial thromboem-
olic disease, familial hypercholesterolemia, body mass in-
ex 32 kg/m2, alcohol abuse, or current participation in
ther studies. The study protocol was approved by the
thical Committee of the Karolinska Hospital, and all
ubjects gave informed consent to participate. Participants
ere served a mixed meal (Karlshamns Oil & Fat, Karl-
hamn, Sweden) that had a total energy content of 1,000
cal, with 60% of energy from fat, 13% from protein, and
7% from carbohydrates. Blood samples were drawn before
he meal and then hourly for 6 h.
RL subfractionation. Triglyceride-rich lipoproteins
ere subfractionated by cumulative density gradient ultra-
entrifugation (19). In brief, the densities of plasma samples
btained before and 3 and 6 h after the meal were increased
nd subjected to cumulative ultracentrifugation to float
ipoprotein fractions with Svedberg flotation (Sf) rates
400, Sf 60 to 400, and Sf 20 to 60, which were aspirated
rom the top of tube. After the last run, Sf 12 to 20
ipoproteins were isolated 29 mm from the top of the tube;
poB100 and apo48 concentrations were determined in each
ensity fraction; apoCI levels were measured in plasma
amples and in the Sf 20 to 400 fraction isolated from the
ame plasma samples.
asting and postprandial measurements. Very-low-
ensity lipoprotein (VLDL), low-density lipoprotein, and
igh-density lipoprotein cholesterol and triglyceride con-
entrations were determined by preparative ultracentrifuga-
ion, precipitation of apoB-containing lipoproteins, and
ipid analyses (20). Plasma triglycerides were measured with
colorimetric assay (450032, Boehringer Mannheim, Indi-
napolis, Indiana; Wako Chemicals GmbH, Neuss, Ger-
any). Plasma cholesterol concentrations were determined
nzymatically (Merck, Darmstadt, Germany); apoB100 and
poB48 concentrations in TRL fractions were determined
Abbreviations and Acronyms
apo  apolipoprotein
CHD  coronary heart disease
IMT  intima-media thickness
Sf  Svedberg flotation
TRL(s)  triglyceride-rich lipoprotein(s)
VLDL  very-low-density lipoproteins described (19). The apoCI concentrations in plasma and in the Sf 20 to 400 TRL fraction were determined with an
nzyme immunoassay (21). Fasting insulin and proinsulin
evels in fasting, heparinized plasma were measured by
LISA (DAKO Insulin and Intact Proinsulin, DAKO
iagnostics Ltd., Bagsvaerd, Denmark) and glucose by a
lucose oxidase measurement (Kodak, Ektachem, Roches-
er, New York). The apoE genotype was determined as
escribed (22).
arotid artery ultrasound examination. Carotid artery
MT was measured according to the ultrasound protocol of
he European Lacipidine Study on Atherosclerosis (23).
he scans were performed with an 8-MHz, high-
esolution, annular-array scanner (A2000 II sa, Biosound,
nc., Indianapolis, Indiana), recorded on S-VHS videotape,
nd evaluated at the Center for Medical Ultrasound, Divi-
ion of Vascular Ultrasound Research, Wake Forest Uni-
ersity, Winston-Salem, North Carolina. The common
arotid far-wall IMT (mean of right and left artery regis-
rations) was used as a measure of early atherosclerosis. The
xaminations were performed by two sonographers. Their
oefficients of variation between readings were 3.8% and
.1%. The coefficient of variation between the sonographers
as 4.7%.
alculations and statistical methods. The apoCI content
f TRL particles was calculated by dividing the molarity of
poCI by that of apoB. The molarities were calculated from
he fractional (i.e., Sf 20 to 400) concentrations of apoCI
nd apoB. Variables with skewed distribution were log-
ormalized before statistical analysis. Univariate associa-
ions between clinical or metabolic variables and IMT were
ssessed by Pearson correlation coefficients; variables that
ere significantly associated with IMT were included in the
ultivariate analysis. The multivariate model was generated
y multiple stepwise linear regression analysis to identify
ariables that were independently associated with IMT. A
orward approach was used in which significance levels were
et at 0.25 to enter the model and at 0.10 to leave the
odel. All statistical sets were two-sided, and p  0.05 was
onsidered significant.
ESULTS
haracteristics of the study group. The basic characteris-
ics of the study group are summarized in Table 1. Twenty-one
f the 72 men were current smokers, and 25 were former
mokers. As expected from the entry criteria, very few subjects
ad a family history of CHD, and the ultrasound examination
evealed a fairly normal IMT. Not surprisingly, given the
ealth of the group, IMT did not correlate with blood
ressure, hip/waist ratio, or body mass index.
asting plasma lipid and lipoprotein concentrations and
lucose-insulin homeostasis. Intima-media thickness cor-
elated significantly with the fasting plasma concentrations
f proinsulin, cholesterol, and VLDL, and low-density
ipoprotein cholesterol (r  0.30, 0.28, 0.25, and 0.27,
espectively, p  0.05) (Table 2). Fasting triglyceride and
nsulin levels also correlated positively, but not significantly,
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April 5, 2005:1013–7 Apolipoprotein CI and Early Atherosclerosisith IMT (r  0.19 and 0.21, p  0.05); IMT did not
orrelate with high-density lipoprotein cholesterol, VLDL
riglycerides, or glucose.
ostprandial plasma TRL concentrations. Plasma tri-
lyceride concentrations during the first 4 h after the meal
orrelated significantly with IMT (Fig. 1); a particularly
trong correlation was seen at 2 h (r  0.34, p  0.01).
part from the concentration of large apoB100-containing
LDL particles (i.e., the apoB100 concentration in the Sf
0 to 400 fraction) at 3 h (r  0.23, p  0.05), neither the
asting nor the postprandial TRL particle concentrations
i.e., apoB concentrations in the Sf 20 to 60 or Sf 60 to 400
ractions) correlated with IMT (Table 3). In contrast, a
orrelation was seen between fasting plasma intermediate-
ensity lipoprotein concentration and IMT (r  0.24, p 
.05).
poCI. Intima-media thickness correlated significantly
ith postprandial, but not fasting, apoCI concentrations
Table 4). Most striking was the correlation between IMT
able 1. Basic Characteristics of the Study Group
o. of subjects 72
amily history of CHD*, % 8
moker, n 46
Current 21
Former 25
lcohol intake, g/day 18  15
MI, kg/m2 25.2  2.5
aist/hip ratio 0.93  0.06
lood pressure, mm Hg
Systolic 122  12
Diastolic 79  7.8
ommon carotid artery IMT, mm
Far wall 0.85  0.15
Near wall 0.86  0.13
Diagnosis of CHD in a first-degree relative 60 years old. Values are mean  SD.
BMI  body mass index; CHD  coronary heart disease; IMT  intima-media
hickness.
able 2. Fasting Plasma Glucose, Insulin, Cholesterol, and
riglyceride Concentrations in Plasma and Major Lipoprotein
ractions and Relationships to the Common Carotid
rtery IMT
Mean  SD
Correlation With IMT,
r*
lucose, mmol/l 4.7  0.5 0.02
nsulin, pmol/l 41  34 0.19
roinsulin, pmol/l 3.7  3.4 0.30†
holesterol, mmol/l
Plasma 5.36  0.92 0.28†
VLDL 0.69  0.81 0.25†
LDL 2.96  1.45 0.27†
HDL 1.36  0.51 0.03
riglycerides, mmol/l
Plasma 1.29  1.28 0.21
VLDL 0.64  0.42 0.02
LDL 0.42  0.33 0.10
HDL 0.11  0.03 0.06
Pearson correlation coefficient; †p  0.05.
HDL  high-density lipoprotein; IMT  intima-media thickness; LDL 
ow-density lipoprotein; VLDL  very low-density lipoprotein. dnd the TRL apoCI content (r 0.37, p 0.002, Table 4).
he TRL apoCI concentration also correlated strongly with
he VLDL cholesterol concentration (Fig. 2).
ultivariate analysis. Multivariate analysis demonstrated
ignificant independent associations between IMT and
asting plasma cholesterol (p 0.05), plasma triglycerides at
h (p  0.006), and the TRL apoCI content at 6 h (p 
.0001). The fasting plasma cholesterol concentrations ac-
ounted for 5% of the variation in IMT, whereas postpran-
ial plasma triglyceride and the TRL apoCI concentrations
ccounted for 14% each.
igure 1. The plasma triglyceride concentrations before and after a
tandardized mixed meal containing 1,000 kcal (60% of energy from fat) in
2 healthy 50-year-old men. Pearson correlation coefficient (r) to intima-
edia thickness and *p  0.05; †p  0.01.
able 3. Fasting and Postprandial ApoB100 and ApoB48
oncentrations in Lipoprotein Subfractions
Fraction
Time (h)
0 3 6
f 400
ApoB100 0.03  0.06 0.21  030 0.16  0.33
r  0.13 r  0.09 r  0.02
ApoB48 0.01  0.04 0.23  0.22 0.12  0.22
r  0.05 r  0.14 r  0.03
f 60 to 400
ApoB100 19.4  17.1 28.9  18.9 21.6  20.9
r  0.11 r  0.23* r  0.17
ApoB48 0.34  0.49 1.32  0.98 0.78  0.93
r  0.10 r  0.06 r  0.06
f 20 to 60
ApoB100 30.3  16.9 25.8  12.4 30.1  16.6
r  0.01 r  0.07 r  0.00
ApoB48 0.51  0.38 0.74  0.40 0.51  0.37
r  0.13 r  0.02 r  0.00
DL
ApoB100 48.0  23.0 ND ND
r  0.24*
ApoB48 0.14  0.21 ND ND
r  0.02
alues are mean  SD (mg/dl). r values indicate Pearson correlation coefficients with
ntima-media thickness. *p  0.05.Apo  apolipoprotein; IDL  intermediate-density lipoprotein; ND  not
etermined; Sf  Svedberg flotation.
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Apolipoprotein CI and Early Atherosclerosis April 5, 2005:1013–7ISCUSSION
his study shows that the postprandial plasma triglyceride
oncentration at 2 h and the apoCI content of TRL
articles at 6 h are independent predictors of early athero-
clerosis. The TRL apoCI content also correlated strongly
ith the TRL cholesterol concentration. Because the latter
i.e., VLDL cholesterol) was not an independent marker of
arly atherosclerosis, we suspect that the postprandial trans-
er of apoCI from high-density lipoprotein to TRL particles
ccurs before cholesterol enrichment, supporting the notion
hat TRL apoCI concentration governs the cholesterol
nrichment of remnants and contributes to the development
f early atherosclerosis.
To identify early atherosclerosis, we used B-mode ultra-
ound to measure the IMT of the common carotid artery.
he validity of this surrogate measurement is supported by
everal observations. Common carotid IMT measured by
ltrasound correlates well with that measured by light
icroscopy (24) and with many risk factors for atheroscle-
otic disease, including smoking, hypertension, and age
25). It also reflects the severity of atherosclerotic coronary
rtery disease (26,27) and predicts future cardiac events (28).
owever, whether IMT can be used to predict future
therosclerosis risk remains unproven. Age, gender, and
poE genotype are strong determinants of common carotid
MT (26,27,29,30). Therefore, we included only 50-year-
ld men with an apoE3/E3 genotype.
Several years ago, we used this technique in a study of fasting
nd postprandial risk factor profiles in relation to early athero-
clerosis in 96 healthy 50-year-old men with an apoE3/E3
enotype (31). In the current study, we reanalyzed 72 of these
en to assess the role of apoCI plasma and the TRL
oncentrations. As in this previous study, several established risk
actors of CHD were associated with early atherosclerosis—
lasma cholesterol, low-density lipoprotein cholesterol, proinsulin,
lasma triglyceride concentration at 2 h, apoB100 in VLDL at
h, and baseline level of intermediate-density lipoproteins (31).
able 4. Fasting and Postprandial ApoCI Concentrations in
lasma, TRL Subfractions, and TRL Particles
Time (h)
0 6
lasma
ApoCI (mg/dl) 170  66.8 170  63.7
r  0.17 r  0.27*
f 20 to 400
ApoCI (mg/dl) 18.6  15.7 17.0  13.5
r  0.03 r  0.24*
f 20 to 400
ApoCI per TRL particle
(mol. apoCI/mol. apoB)
28.0  22.3 29.7  17.8
r  0.04 r  0.37†
alues are mean  SD. The r values indicate Pearson correlation coefficients with
ntima-media thickness. *p  0.05; †p  0.002.
ApoCI  apolipoprotein CI; mol.  molecules; Sf  Svedberg flotation; TRL 
riglyceride-rich lipoprotein.otably, however, the postprandial TRL apoCI concentration
a
fas an even stronger predictor of early atherosclerosis in these
en. These results suggest that apoCI-rich TRLs are atherogenic.
Apolipoprotein CI is probably the least studied member of
he apoC family. This is surprising because apoCI has prop-
rties that clearly distinguish it from other family members
11). For instance, in contrast to CIII, apoCI does not block
he hydrolysis of TRLs by lipoprotein lipase but, like apoCIII,
t does block apoE-mediated clearance of TRLs by receptors.
n the fasting state, about 90% of apoCI is associated with
igh-density lipoprotein, whereas apoCII and apoCIII are
qually distributed between TRLs and high-density lipopro-
ein. In the postprandial state, the transfer of apoCI from
igh-density lipoprotein to TRLs is greater than that of
poCII and CIII (32). Thus, the metabolic properties of
poCI are consistent with an increased half-life of TRL
emnants in the circulation, which, in turn, would increase its
holesterol ester/triglyceride ratio. Consistent with this notion,
holesterol-rich remnants accumulate in the plasma of mice
ver-expressing apoCI (14).
In addition to the apoCI content of TRL particles,
asting plasma cholesterol and the postprandial plasma
riglyceride concentration independently predicted IMT.
he apoCI content of TRL particles did not correlate with
arly postprandial triglyceride concentration. In contrast,
here was a strong correlation between the concentrations of
poCI and cholesterol in TRL particles (Fig. 2), suggesting
hat the apoCI on TRL particles is associated with partic-
larly atherogenic cholesterol or cholesterol that is more
ikely to end up in the arterial wall. However, whether
poCI in itself is atherogenic or whether apoCI is athero-
enic by increasing TRL cholesterol ester content cannot be
istinguished in this study. In fact, it is an inherent difficulty
o exclude noncausal relationships when using a study
esign as the one chosen for this study.
We had speculated that the strong association between
ostprandial triglycerides and IMT in our previous study
31) might be explained by the effects of apoCI on post-
randial triglyceride metabolism. The lack of association
etween the apoCI content of TRL particles and postpran-
ial triglyceride concentration does not support this hypoth-
igure 2. Regression plot of the log-normalized (ln) cholesterol and
polipoprotein (apo) CI concentrations of the Svedberg flotation 20 to 400
raction. *p  0.0001. VLDL  very-low-density lipoprotein.
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April 5, 2005:1013–7 Apolipoprotein CI and Early Atherosclerosissis. Further studies are required to better understand
hether these two variables are independent risk factors for
arly atherosclerosis or merely reflect a more general per-
urbation of postprandial TRL metabolism.
otential clinical implications. The current study adds
he TRL content of apoCI to the list of potential risk factors
or premature development of atherosclerosis. Longitudinal
tudies are warranted to assess the usefulness of the apoCI
RL content as a marker of individuals with increased
HD risk. For future clinical use, we foresee the develop-
ent of a clinical test device containing two immunoabsor-
ent steps: the first step with antibodies retaining apoB100-
ontaining TRLs from postprandial plasma, which then
hould be passed on to a second step retaining and apoCI-
ontaining particles from the apoB100-containing TRLs.
nterestingly, because postprandial plasma is required, it
ight be valuable to ask patients to visit the clinic non-
asted. According to the results of the current study, the
holesterol/protein ratio of the retained fraction from this
bsorbent (the apoB100- and apoCI-containing TRL frac-
ion retained in the second step) should potentially indicate
he level of CHD risk.
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